Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Short Interest in Prospect Capital NYSEPSEC on the Rise

Elaine Mendonca by Elaine Mendonca
March 14, 2024
in Breaking News
0
Finances
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Short interest in Prospect Capital (NYSE:PSEC) has surged by 25.65% since the latest update on March 14, 2024, with 22.51 million shares being sold short, accounting for 7.79% of the total regular shares available for trading. Traders would need an average of 6.84 days to cover their short positions based on the current trading volume.

The level of short interest is a key indicator of market sentiment towards a particular stock. A rise in short interest can suggest a bearish outlook, while a decrease may indicate bullishness. Prospect Capital’s short interest ratio stands at 10.0, signaling significant pessimism surrounding the stock. In comparison to peers in the finance sector, Prospect Capital’s short interest percentage of 6.31% is higher than competitors such as Golub Capital BDC, Inc. (2.24%) and Capital Southwest Co. (2.49%).

A short interest below 10% is generally viewed positively, while anything above 10% is considered high, and over 20% indicates widespread negativity. Prospect Capital has seen a recent decline in short interest, with traders shorting 19,420,000 shares as of December 31st. Short squeezes can occur when a stock with high short interest experiences a price increase, leading short sellers to buy shares to cover their positions, further boosting the stock price.

Short interest reports are typically released monthly by stock exchanges, with NASDAQ providing bi-monthly reports for U.S. stocks like PSEC.

Prospect Capital Corporation (PSEC) Stock Price Analysis: March 14, 2024

On March 14, 2024, Prospect Capital Corporation (PSEC) experienced a slight drop in its stock price. The stock opened at $5.63, which was $0.05 higher than its previous close. Throughout the trading day, the price of PSEC shares decreased by $0.04, resulting in a 0.63% drop by the time the market closed.

PSEC is currently trading in the middle of its 52-week range and below its 200-day simple moving average. This indicates that the stock’s performance may be relatively stable compared to its previous highs and lows, but it is still lagging behind its long-term trend.

Investors and analysts may be monitoring PSEC closely to see if the stock can regain momentum and break above its 200-day moving average. Crossing this key technical indicator could signal a potential uptrend in the stock’s price.

Prospect Capital Corporation (PSEC) Financial Performance Analysis: Revenue Up, Net Income Down

On March 14, 2024, Prospect Capital Corporation (PSEC) saw some significant changes in its financial performance compared to the previous year and quarter. According to data from CNN Money, the total revenue for the company was reported at $811.17 million for the past year, showing an increase of 16.26% from the previous year. However, the total revenue for the second quarter of the fiscal year was $211.06 million, indicating a substantial increase of 633.99% from the previous quarter.

In contrast, the net income for Prospect Capital Corporation showed a decline in both the yearly and quarterly comparisons. The net income for the past year was reported at -$101.64 million, reflecting a decrease of 117.45% from the previous year. Similarly, the net income for the second quarter was reported at -$27.74 million, showing a decrease of 123.78% from the previous quarter.

Furthermore, the earnings per share (EPS) for Prospect Capital Corporation also experienced a decline in both the yearly and quarterly comparisons. The EPS for the past year was reported at -$0.43, indicating a decrease of 132.23% from the previous year. Similarly, the EPS for the second quarter was reported at -$0.13, showing a decrease of 170.34% from the previous quarter.

Overall, the financial performance of Prospect Capital Corporation on March 14, 2024, showed mixed results with an increase in total revenue but decreases in net income and earnings per share. Investors and analysts may want to closely monitor the company’s future performance to assess its financial health and growth prospects.

Tags: PSEC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
DVY stock news

Mixed Analyst Opinions on WW Graingers Price Target

Advancing Chronic Kidney Disease Management through Genetic Testing Natera Endorses 2024 KDIGO Clinical Practice Guideline

Biotechnology Trading online

Ascendis Pharma A Remarkable Investment Success Story

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com